Publication & Citation Trends
Publications
683 total
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
Cited by 293
OpenAlex
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Cited by 526
OpenAlex
Research Topics
Lung Cancer Diagnosis and Treatment
(112)
Esophageal Cancer Research and Treatment
(73)
Lung Cancer Treatments and Mutations
(53)
Gastric Cancer Management and Outcomes
(53)
Cancer-related molecular mechanisms research
(43)
Affiliations
South China Agricultural University
Shanghai University
Tongji University
Tri-Service General Hospital
Fujian Medical University